From: The Lebanese left ventricular assist device experience, a success story despite the odds
Mean age (years) | 49.8 ± 12.7 |
---|---|
Female | (25) 32% |
Diabetes | (32) 41% |
Hypertension | (32) 41% |
Dyslipidemia | (34) 44% |
Smoking | (25) 32% |
Body mass index (Kg/m2) | 24.9 ± 3.1 |
Previous CABG | (11) 14% |
Creatinine | 1.4 ± 0.4 |
ICD/CRTD | (65) 83% |
Mean LVEF (%) | 18 ± 2.8 |
LVEDD (mm) | 73 ± 5.1 |
TAPSE (mm) | 14.9 ± 3.9 |
CVP (mmHg) | 13.7 ± 4.0 |
Cardiac index (l/mn/m2) | 1.7 ± 0.3 |
INTERMACS | 2.0 ± 0.4 |
BTT | (41) 53% |
DT | (33) 42% |
BTR | (4) 5% |
ECMO | (9) 11.6% |
IABP | (4) 5% |